Ezetimibe
Rank #138 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$118.1M
Total Cost
2,859,001
Total Claims
$118.1M
Total Cost
60,846
Prescribers
$41
Cost per Claim
681,047
Beneficiaries
7,056,413
30-Day Fills
$1,941
Avg Cost/Provider
47
Avg Claims/Provider
Share of Medicare Part D Spending
0.04%
of total Medicare Part D spending
$118.1M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $118.1M total
Top Prescribers of Ezetimibe
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Henry Yee | Cardiology | Alhambra, CA | 2,081 | $117K |
| 2 | Roberto Cowley | Nurse Practitioner | Doral, FL | 505 | $101K |
| 3 | John Isaac | Cardiology | Houston, TX | 1,663 | $80K |
| 4 | Cres Miranda | Cardiology | Las Vegas, NV | 1,858 | $79K |
| 5 | Don Lee | Interventional Cardiology | Glendale, CA | 1,370 | $75K |
| 6 | Ramiro Rodriguez | General Practice | Homestead, FL | 607 | $60K |
| 7 | Brian Heaster | Internal Medicine | Darlington, SC | 54 | $60K |
| 8 | Su Yong Pak | Internal Medicine | Lynnwood, WA | 1,141 | $59K |
| 9 | Enrique Griego | Family Practice | Mcallen, TX | 1,254 | $58K |
| 10 | Michael Harris | Internal Medicine | Bend, OR | 982 | $57K |
| 11 | Dae Rheem | Gastroenterology | Los Angeles, CA | 1,331 | $57K |
| 12 | Ronald Hart | Family Practice | Yuba City, CA | 988 | $55K |
| 13 | Ray Hsiao | Internal Medicine | Hacienda Heights, CA | 776 | $53K |
| 14 | Isaac Snapp | Physician Assistant | Darlington, SC | 43 | $51K |
| 15 | James Barnett | Interventional Cardiology | Midland, TX | 1,181 | $48K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 135 | Empagliflozin/Metformin Hcl (Synjardy Xr) | $119.7M | 121,366 |
| 136 | Edaravone (Radicava Ors) | $119.6M | 8,588 |
| 137 | Insulin Regular, Human (Afrezza) | $119.4M | 143,017 |
| 138 | Ezetimibe (Ezetimibe) | $118.1M | 2,859,001 |
| 139 | Ambrisentan (Ambrisentan) | $117.7M | 23,927 |
| 140 | Memantine Hcl (Memantine Hcl) | $117.5M | 2,268,098 |
| 141 | Estradiol (Estradiol) | $115.7M | 1,412,386 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology